Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
7TM Pharma A/S
Deal entered with Ortho-McNeil to develop compounds for asthma, allergies
July 6th, 2005
7TM Pharma A/S announced that it has entered into an exclusive worldwide license agreement and research collaboration with Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson company, to further develop 7TM Pharma's program on novel oral compounds for the treatment of asthma and allergic diseases. Under the agreement, 7TM Pharma will receive an upfront fee, research funding and milestones, as well as royalties on sales for each compound developed under the collaboration. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), also a Johnson & Johnson company, will be responsible for the development of compounds resulting from the...
Source: Biotech Week (2005-07-06)
|
